Introduction:Basic information about CAS 76932-56-4|(D-2-Nal6)-LHRH acetate salt, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | (D-2-Nal6)-LHRH acetate salt |
|---|
| CAS Number | 76932-56-4 | Molecular Weight | 1322.471 |
|---|
| Density | 1.5±0.1 g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C66H83N17O13 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | Nafarelin |
|---|
| Synonym | More Synonyms |
|---|
(D-2-Nal6)-LHRH acetate salt BiologicalActivity
| Description | Nafarelin is a gonadotropin-releasing hormone (GnRH) agonist that stimulates secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Sequence: {Glp}-His-Trp-Ser-Tyr-{2-Naph-Ala}-Leu-Arg-Pro-Gly-NH2. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>GNRH ReceptorPeptidesResearch Areas >>Cancer |
|---|
| Target | GnRH[1]. |
|---|
| In Vitro | Nafarelin is a gonadotropin-releasing hormone (GnRH) agonist that stimulates secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)[1]. Nafarelin is used effectively in in vitro fertilisation programmes. Nafarelin is readily and rapidly absorbed following intranasal delivery, and is protected to some extent from enzymatic degradation GnRH[2]. |
|---|
| References | [1]. Letassy NA et al. Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis. DICP. 1990 Dec, 24(12):1204-9. [2]. Chrisp P et al. Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions.Drugs. 1990 Apr;39(4):523-51. |
|---|
Chemical & Physical Properties
| Density | 1.5±0.1 g/cm3 |
|---|
| Molecular Formula | C66H83N17O13 |
|---|
| Molecular Weight | 1322.471 |
|---|
| Exact Mass | 1321.635620 |
|---|
| PSA | 472.13000 |
|---|
| LogP | 0.89 |
|---|
| Index of Refraction | 1.711 |
|---|
| InChIKey | RWHUEXWOYVBUCI-ITQXDASVSA-N |
|---|
| SMILES | CC(C)CC(NC(=O)C(Cc1ccc2ccccc2c1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(N)=O |
|---|
| Storage condition | -20°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- OK6371150
- CHEMICAL NAME :
- Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-
- CAS REGISTRY NUMBER :
- 76932-56-4
- LAST UPDATED :
- 199703
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C66-H83-N17-O13
- MOLECULAR WEIGHT :
- 1322.66
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 448 ug/kg/8W-I
- TOXIC EFFECTS :
- Nutritional and Gross Metabolic - changes in potassium
- REFERENCE :
- LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 347,333,1996
|
Synonyms
| (2S)-N-(2-amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-(2-methylpropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxopyrrolidin-2-yl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}pyrrolidine-2-carboxamide (non-preferred name) |
| Nacenyl |
| (2S)-N-(2-Amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-isobutyl-8-(2-naphthylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxopyrrolidin-2-yl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}pyrrolidine-2-carboxamide (non-preferred name) |
| Nafareline |
| UNII:1X0094V6JV |
| Synarel |
| (2S)-N-(2-Amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-isobutyl-8-(2-naphthylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxo-2-pyrrolidinyl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}-2-pyrrolidinecarboxamide |
| 6-(3-(2-Naphthalenyl)-D-alanine)luteinizing Hormone-releasing Factor |
| glycinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthalenyl)-D-alanyl-L-leucyl-L-arginyl-L-prolyl- |
| Synrelina |
| Nasanyl |
| Nafarelin Acetate |